Press release
Roche, AstraZeneca Market Share in North America and Europe PEGylated Drugs Market|Key Players: Pfizer, Amgen, Biogen
North America and Europe PEGylated Drugs Market
Increasing R&D investment of biotechnology & pharmaceutical companies to develop enhanced PEGylated drugs for treatment of various chronic diseases along with rising occurrence of chronic ailments in developed regions will propel PEGylated drugs market growth over the forecast period. Major advancements in biologics sector including advances in drug antibody conjugates, and immunotherapies will positively impact market growth.
Moreover, rising incidences of chronic ailments and increasing death rates associated with cancer in Canada will propel industry growth. However, the side-effects associated with pegylated drugs along with drug failure will impede PEGylated drugs market growth over the forecast timeframe.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2511
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
• Roche
• AstraZeneca
• Pfizer
• Amgen
• Biogen
• Novo Nordisk
• UCB
• Merck KGaA
Cancer segment held over 60% of the overall market share in 2017 due to growing prevalence of the disease creating a demand for the development of effective drugs. Benefits offered by PEGylated drugs such as reduced proteolytic degradation along with minimized immunogenicity leading to enhanced therapeutic efficacy will propel market growth. Increasing areas of applications as well as rising adoption of PEGylated drugs to treat various types of cancer will stimulate business growth.
Hepatitis segment size was USD 156 million in 2017 and is anticipated to follow a declining trend over the forecast period. However, increasing focus of industry players to develop pegylated drugs used for the treatment of such chronic conditions will contribute to market growth. For instance, launch of Pegasys drug used for treating Hepatitis C in adult patients will fuel market growth.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2511
North America & Europe PEGylated Drugs Market by Disease Indication
o Cancer
o Hepatitis
o Multiple sclerosis
o Gastrointestinal disorders
North America & Europe PEGylated Drugs Market by Type
o Monoclonal antibodies (mAbs)
o Colony stimulating factors
o Interferons
Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.
Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Roche, AstraZeneca Market Share in North America and Europe PEGylated Drugs Market|Key Players: Pfizer, Amgen, Biogen here
News-ID: 1472468 • Views: …
More Releases from Global Market Insights
Acoustic Diaphragm Market slated to observe traction for polypropylene material …
With a seismic rise in the demand for consumer products such a loudspeakers, mobile phones and earphones, acoustic diaphragm market size is slated to surge in the next five years. Notably, acoustic diaphragm tends to inter-convert mechanical vibration to sounds and has become highly popular in headphones and speakers.
Market penetration of materials such as paper, polycarbonate, polypropylene, carbon fiber and aluminum has become more pronounced in the past several…
How will increasing demand for stainless steel transform the Ferroalloys Market …
One of the recent breakthroughs in the global ferroalloys market is the potential acquisition of Ferro Alloys Corporation by Vedanta- a natural resource company early this year. As per reliable sources, the acquisition is expected to complement Vedanta’s current steel business considering the fact that integration of Ferro manufacturing capabilities would offer the possibility to generate significant efficiencies.
Meanwhile, yet other company, Boston Metal has declared having raised over USD 20…
Polyphenylsulfone Market 2021 | Regional Insights & Growth Forecast To 2025
The polyphenylsulfone market will witness significant expansion with the rise in healthcare concerns and the growing requirement for biocompatible products. Polyphenylsulfone is a high-performance thermoplastic that is amorphous, heat-resistant, and transparent. It showcases high sterilization properties and is widely employed as an alternative for polyetheretheketone and polyaryletherketone. Furthermore, the polymer sees large adoption across various verticals of the healthcare sector to offer superior dimensional stability and higher resistance against…
Cosmetic Contact Lens Market 2021: Industry Growth, Competitive Analysis, Future …
Increasing trend of using colored contact lenses may have a positive impact on cosmetic contact lens market outlook. Rising popularity of customized lenses with attractive colors, shades and textures for improving eye appearance is likely to propel industry size. Proliferation of entertainment, online and social media platforms are helping boost the adoption of such lenses.
Cosmetic contact lenses are available in several colors such as blue, green, brown, hazel, grey, violet…
More Releases for PEGylated
PEGylated Proteins Market: Competitive Dynamics & Global Outlook 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global PEGylated Proteins market.
PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of therapeutic proteins since the first PEGylated product was approved by Food and Drug Administration in the early 1990s.
Click to view the full report TOC, figure and tables:
https://www.marketresearchreportstore.com/reports/2882/global-pegylated-proteins-market
Global PEGylated Proteins Market: Forecast by…
PEGylated Proteins Market Striking over 2024
Global PEGylated Proteins Market: Snapshot
The development of the healthcare industry and the introduction of new drugs and therapeutics are the key factors estimated to encourage the growth of the global PEGylated proteins market in the next few years. The rising number of lifestyle disorders and the growing demand for effective therapeutics are boosting the demand for PEGylated proteins. In addition, the increasing focus on research and developing activities and innovations…
PEGylated Proteins Market : Industry Perspective and Comprehensive Analysis 2024
Global PEGylated Proteins Market: Snapshot
The development of the healthcare industry and the introduction of new drugs and therapeutics are the key factors estimated to encourage the growth of the global PEGylated proteins market in the next few years. The rising number of lifestyle disorders and the growing demand for effective therapeutics are boosting the demand for PEGylated proteins. In addition, the increasing focus on research and developing activities and innovations…
PEGylated Proteins Market to See Incredible Growth
The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation. PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic binding, confirmation, and hydrophobicity of the molecule. PEGylation decreases the dose frequency by reducing renal excretion and proteolysis, and increases tension time of conjugates in…
Segment-level analysis On PEGylated Proteins Market
Global PEGylated Proteins Market was worth USD 690.6 million in 2016 and estimated to be growing at a CAGR of 10.50%, to reach USD 1.137 billion by 2021.
The market is showing great potential in the forecast period, i.e. till 2021. PEGylation is a process of attachment of covalent or non-covalent bond of PolyEthylene Glucol (PEG) polymer chains to molecules and macrostructures, like protein in case of PEGylation of proteins.…
PEGylated Proteins 2024 Market Research Report
The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation. PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic binding, confirmation, and hydrophobicity of the molecule. PEGylation decreases the dose frequency by reducing renal excretion and proteolysis, and increases tension time of conjugates in…
